Indrapr.Medical

  • Market Cap: Small Cap
  • Industry: Hospital
  • ISIN: INE681B01017
  • NSEID: INDRAMEDCO
  • BSEID: 532150
INR
416.20
-20.45 (-4.68%)
BSENSE

May 12

BSE+NSE Vol: 3.55 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 131877,
    "name": "Indrapr.Medical",
    "stock_name": "Indrapr.Medical",
    "full_name": "Indraprastha Medical Corporation Ltd",
    "name_url": "stocks-analysis/indraprmedical",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "416.20",
    "chg": -20.45,
    "chgp": "-4.68%",
    "dir": -1,
    "prev_price": "436.65",
    "mcapval": "3,949.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 532150,
    "symbol": "INDRAMEDCO",
    "ind_name": "Hospital",
    "ind_code": 94,
    "indexname": "India SENSEX",
    "isin": "INE681B01017",
    "curr_date": "May 12",
    "curr_time": "",
    "bse_nse_vol": "3.55 lacs",
    "exc_status": "Active",
    "traded_date": "May 12, 2026",
    "traded_date_str": "2026 05 12",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/indraprmedical-131877-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Indraprastha Medical Corporation Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indraprastha-medical-corporation-ltd-is-rated-sell-3987301",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IndraprasthaMed_mojoScore_3987301.png",
        "date": "2026-05-12 10:10:46",
        "description": "Indraprastha Medical Corporation Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 May 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Indraprastha Medical Corporation Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indraprastha-medical-corporation-ltd-is-rated-sell-3972066",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IndraprasthaMed_mojoScore_3972066.png",
        "date": "2026-05-01 10:10:29",
        "description": "Indraprastha Medical Corporation Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Indraprastha Medical Corporation Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indraprastha-medical-corporation-ltd-is-rated-sell-3953799",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IndraprasthaMed_mojoScore_3953799.png",
        "date": "2026-04-20 10:10:48",
        "description": "Indraprastha Medical Corporation Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 January 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 20 April 2026, providing investors with an up-to-date analysis of the company’s standing."
      },
      {
        "title": "Indraprastha Medical Corporation Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indraprastha-medical-corporation-ltd-is-rated-sell-3939372",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IndraprasthaMed_mojoScore_3939372.png",
        "date": "2026-04-09 10:10:32",
        "description": "Indraprastha Medical Corporation Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 January 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 09 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Indraprastha Medical Corporation Ltd Gains 4.07%: Key Momentum Shifts and Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indraprastha-medical-corporation-ltd-gains-407-key-momentum-shifts-and-market-dynamics-3933473",
        "imagepath": "",
        "date": "2026-04-05 17:00:03",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>30 Mar:</strong> Bearish momentum and technical downgrade weigh on stock (Rs.371.65, -3.43%)</p>\n                    <p><strong>1 Apr:</strong> Strong gap up and intraday high with 7.48% surge (Rs.398.90)</p>\n                    <p><strong>2 Apr:</strong> Modest gain continues, closing at Rs.400.50 (+0.40%)</p>\n                    <p><strong>Week Close:</strong> Rs.400.50, overall +4.07% vs Sensex -0.29%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.384.85</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><d..."
      },
      {
        "title": "Indraprastha Medical Corporation Ltd Surges 7.48% to Day's High of Rs 396.05 — Outperforms Sector by 6.8 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indraprastha-medical-corporation-ltd-hits-intraday-high-with-748-surge-3928971",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IndraprasthaMed_priceRelatedfactors_3928971.png",
        "date": "2026-04-01 11:30:54",
        "description": "The Sensex declined by 2.18% on 1 Apr 2026, yet Indraprastha Medical Corporation Ltd surged 7.48%, outperforming its Hospital sector by 6.8 percentage points. This sharp single-session gain rewrites the short-term narrative for the small-cap stock, raising the question of whether this is a genuine recovery or a technical bounce within a broader downtrend."
      },
      {
        "title": "Indraprastha Medical Corporation Ltd Opens 5.19% Higher in Sharp Gap Up, But Can the Technicals Support It?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indraprastha-medical-corporation-ltd-opens-strong-with-significant-gap-up-on-1-apr-2026-3927781",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IndraprasthaMed_gapup_3927781.png",
        "date": "2026-04-01 09:31:31",
        "description": ""
      },
      {
        "title": "Indraprastha Medical Corporation Ltd Faces Bearish Momentum Amid Technical Downgrade",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indraprastha-medical-corporation-ltd-faces-bearish-momentum-amid-technical-downgrade-3923197",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IndraprasthaMed_technicaldot_3923197.png",
        "date": "2026-03-30 08:00:07",
        "description": "Indraprastha Medical Corporation Ltd, a small-cap player in the hospital sector, has experienced a notable shift in its technical momentum, prompting a downgrade in its MarketsMOJO grade from Hold to Sell as of 30 January 2026. The stock’s recent price action and technical indicators signal a bearish trend, reflecting growing investor caution amid broader market pressures and sector-specific challenges."
      },
      {
        "title": "Indraprastha Medical Corporation Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indraprastha-medical-corporation-ltd-is-rated-sell-3922797",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IndraprasthaMed_mojoScore_3922797.png",
        "date": "2026-03-29 10:10:14",
        "description": "Indraprastha Medical Corporation Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      }
    ],
    "total": 416,
    "sid": "131877",
    "stock_news_url": "https://www.marketsmojo.com/news/indraprastha-medical-corporation-131877"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Audited Financial Results And Dividend",
      "datetime": "01-May-2026",
      "details": "Indraprastha Medical Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2026 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 it is hereby informed that a meeting of the Board of Directors of the Company will be held on Tuesday 12th May 2026 inter alia: - a) to consider and approve the audited financial results for the quarter/ year ended 31st March 2026; and b) to consider and recommend dividend if any on equity shares of the Company for the financial year 2025-26. This is for your information and record.",
      "source": "BSE"
    },
    {
      "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
      "datetime": "23-Apr-2026",
      "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Indraprastha Medical Corporation Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24232DL1988PLC030958</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>AA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>ICRA LIMITED</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: PRIYA RANJAN <br/> Designation: AVP CORPORATE AFFAIRS AND LEGAL <br/> EmailId: priya_ranjan@apollohosppitals.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: C P TYAGI <br/> Designation: CHEIF FINANCIAL OFFICER <br/> EmailId: tyagi@apollohospitals.com</div> </div> <div> <br/> Date: 23/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "07-Apr-2026",
      "details": "We enclose herewith copies of the public notice of the request received under Special window for re-lodgment of transfer request for physical shares published on 7th April 2026 in the Financial express all India editions in English Language and in Jansatta Delhi edition in Hindi language. This is for your information and record.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "(12 May 2026)"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Indraprastha Medical Corporation Ltd has declared <strong>45%</strong> dividend, ex-date: 18 Sep 25",
          "dt": "2025-09-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Indraprastha Medical Corporation Ltd Gains 4.07%: Key Momentum Shifts and Market Dynamics

2026-04-05 17:00:03

Key Events This Week

30 Mar: Bearish momentum and technical downgrade weigh on stock (Rs.371.65, -3.43%)

1 Apr: Strong gap up and intraday high with 7.48% surge (Rs.398.90)

2 Apr: Modest gain continues, closing at Rs.400.50 (+0.40%)

Week Close: Rs.400.50, overall +4.07% vs Sensex -0.29%

stock-recommendationAnnouncement

Board Meeting Intimation for Audited Financial Results And Dividend

01-May-2026 | Source : BSE

Indraprastha Medical Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2026 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 it is hereby informed that a meeting of the Board of Directors of the Company will be held on Tuesday 12th May 2026 inter alia: - a) to consider and approve the audited financial results for the quarter/ year ended 31st March 2026; and b) to consider and recommend dividend if any on equity shares of the Company for the financial year 2025-26. This is for your information and record.

Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

23-Apr-2026 | Source : BSE

Format of Initial Disclosure to be made by an entity identified as a Large Corporate.

Sr. No. Particulars Details
1Name of CompanyIndraprastha Medical Corporation Ltd
2CIN NO.L24232DL1988PLC030958
3 Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr) 0.00
4Highest Credit Rating during the previous FY AA
4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)ICRA LIMITED
5Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the frameworkBSE


We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No



Name of the Company Secretary: PRIYA RANJAN
Designation: AVP CORPORATE AFFAIRS AND LEGAL
EmailId: priya_ranjan@apollohosppitals.com
Name of the Chief Financial Officer: C P TYAGI
Designation: CHEIF FINANCIAL OFFICER
EmailId: tyagi@apollohospitals.com

Date: 23/04/2026

Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

Announcement under Regulation 30 (LODR)-Newspaper Publication

07-Apr-2026 | Source : BSE

We enclose herewith copies of the public notice of the request received under Special window for re-lodgment of transfer request for physical shares published on 7th April 2026 in the Financial express all India editions in English Language and in Jansatta Delhi edition in Hindi language. This is for your information and record.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

(12 May 2026)

stock-summary
DIVIDEND

Indraprastha Medical Corporation Ltd has declared 45% dividend, ex-date: 18 Sep 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available